[HTML][HTML] Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects
Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The
aim of the present review is to report the available evidence on the interaction between …
aim of the present review is to report the available evidence on the interaction between …
NETosis and the immune system in COVID-19: mechanisms and potential treatments
NETosis is a form of neutrophil death leading to the release of extracellular chromatin and
the assembling of proteins, including antiviral proteins, primed by an initial pathogenic …
the assembling of proteins, including antiviral proteins, primed by an initial pathogenic …
Humoral-and T-cell–specific immune responses to SARS-CoV-2 mRNA vaccination in patients with MS using different disease-modifying therapies
Background and Objectives To evaluate the immune-specific response after full severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination of patients with …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination of patients with …
ImmunosuppressiveTherapies differently modulate Humoral-and T-cell-specific responses to COVID-19 mRNA vaccine in rheumatoid arthritis patients
Objective To assess in rheumatoid arthritis (RA) patients, treated with different
immunosuppressive therapies, the induction of SARS-CoV-2-specific immune response …
immunosuppressive therapies, the induction of SARS-CoV-2-specific immune response …
[HTML][HTML] Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
Objectives The interaction of COVID-19 and tuberculosis (TB) are still poor characterized.
Here we evaluated the immune response specific for Micobacterium tuberculosis (Mtb) and …
Here we evaluated the immune response specific for Micobacterium tuberculosis (Mtb) and …
Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation
SA Baker, S Kwok, GJ Berry, TJ Montine - PLoS One, 2021 - journals.plos.org
Mortality due to Covid-19 is highly associated with advanced age, owing in large part to
severe lower respiratory tract infection. SARS-CoV-2 utilizes the host ACE2 receptor for …
severe lower respiratory tract infection. SARS-CoV-2 utilizes the host ACE2 receptor for …
Kinetics of the B-and T-cell immune responses after 6 months from SARS-CoV-2 mRNA vaccination in patients with rheumatoid arthritis
Objective To assess the kinetics of the humoral and cell-mediated responses after severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in rheumatoid arthritis …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in rheumatoid arthritis …
Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
The world has faced 3 years of the COVID-19 pandemic with billions of infections, millions of
deaths, and a massive economic crisis. Since the pandemic began, scientists have started to …
deaths, and a massive economic crisis. Since the pandemic began, scientists have started to …
Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis
K Dahms, A Mikolajewska, K Ansems… - European journal of …, 2023 - Springer
Background At the end of 2021, the European Medicines Agency (EMA) expanded its
approval for the recombinant human interleukin-1 (IL-1) receptor antagonist Anakinra for the …
approval for the recombinant human interleukin-1 (IL-1) receptor antagonist Anakinra for the …
[HTML][HTML] In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
Objective Baricitinib seems a promising therapy for COVID-19. To fully-investigate its effects,
we in-vitro evaluated the impact of baricitinib on the SARS-CoV-2-specific-response using …
we in-vitro evaluated the impact of baricitinib on the SARS-CoV-2-specific-response using …